INVESTOR DEADLINE: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – ENOB
SAN DIEGO, July 29, 2022 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enochian Biosciences Inc. (NASDAQ: ENOB) securities between January 17, 2018 and June 27, 2022, inclusive (the “Class Period”) have until September 26, 2022 to seek…
Comments Off on INVESTOR DEADLINE: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – ENOB